Edward C. Kuehnle
President chez Catalina Marketing Services, Inc.
Provenance du réseau au premier degré de Edward C. Kuehnle
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
17
| Extinct | Pharmaceuticals: Major | 17 |
Catalina Marketing Services, Inc.
 Catalina Marketing Services, Inc. Advertising/Marketing ServicesCommercial Services Catalina Marketing Retail Services provides behavior-based loyalty marketing products and services to help retail clients to manage customer relationships and accomplish marketing objectives. The firm's clients consist primarily of grocery store chains, with an increasing number of drug store and retail chains. The company is located in St. Petersburg, FL.
1
| Operating Division | Advertising/Marketing Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Edward C. Kuehnle via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| THE INTERPUBLIC GROUP OF COMPANIES, INC. | Advertising/Marketing Services | Director of Finance/CFO | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer | |
| MONSANTO | Wholesale Distributors | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
| AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Miscellaneous Commercial Services | Chief Executive Officer | |
Brighton Biotech, Inc.
 Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
| George Washington University | College/University | Graduate Degree | |
| McGill University | College/University | Doctorate Degree | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin | |
| Seattle Pacific University | College/University | Undergraduate Degree | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Evansville | College/University | Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Toronto East General Hospital Foundation | Director/Board Member | ||
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cancer Treatment Centers of America, Inc.
 Cancer Treatment Centers of America, Inc. Hospital/Nursing ManagementHealth Services Cancer Treatment Centers of America, Inc. operates cancer treatment hospitals. It offers surgical oncology, chemotherapy, radiation therapy, stem cell transplantation, and photodynamic therapy treatments. The firm provides treatments for bladder, colon, kidney, lung, ovarian, pancreatic, and skin cancer. The company was founded by Richard J. Stephenson in 1988 and is headquartered in Schaumburg, IL. | Hospital/Nursing Management | Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| National Physicians Corp. | Corporate Officer/Principal | ||
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
Altasciences Co., Inc.
 Altasciences Co., Inc. Miscellaneous Commercial ServicesCommercial Services Altasciences Co., Inc. engages in the provision of clinical pharmacology development services. It offers bioanalysis and research services, preclinical services, clinical services, and development programs. The company was founded in 1992 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| UNC School of Medicine | College/University | Corporate Officer/Principal | |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
Pamlico BioPharma, Inc.
 Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Biotechnology | Director/Board Member | |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
Perseus Holdings USA LLC
 Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
| Pdi, Inc. (United States) | Chief Executive Officer | ||
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 38 |
| Canada | 7 |
| Irlande | 5 |
| Singapour | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Distribution Services | 4 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 92 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 36 |
| Chairman | 23 |
| President | 17 |
Relations les plus connectées
| Insiders | |
|---|---|
| Mark Corrigan | 29 |
| Charles Rowland | 25 |
| Timothy Rothwell | 24 |
| Christopher Coughlin | 23 |
| Nancy Lurker | 20 |
| Gerald Steiner | 16 |
| Paul Chaney | 12 |
| Brent Hatzis-Schoch | 10 |
| C. Ron Cheeley | 9 |
| Paul W. Finnegan | 8 |
| Markus Jerling | 8 |
| Dawn Viveash | 7 |
| Daniel S. Falter | 5 |
| Michael G. Bechtol | 5 |
| Mark J. Leidy | 5 |
- Bourse
- Insiders
- Edward C. Kuehnle
- Connexions Sociétés
